The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the ...

The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

Imugene Ltd (ASX:IMU) (OTCMKTS:IUGNF) is a clinical-stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to ...

Developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours.

Developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours.

Immunic (IMUX) announced that IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, demonstrated a ...

Fans are finding out exciting information about both, and Oda might even have revealed some exciting information about the ability that Imu holds — all this is made possible with the ancient ...

Here we highlight a subset of our preferred stocks from the screener. Overview: Articore Group Limited operates as an online marketplace for art and design products across Australia, the United ...

A solid end of session rally turned around a rather bleak start to the week, with the ASX 200 closing just 0.2% lower. Suncorp suffered the biggest meltdown despite its ex-dividend status being ...

Learn More S&P/ASX 200 Index (ASX: XJO) stocks are trading just inside the green at 8,419.7 points in late afternoon trade on Tuesday. The ASX 200 dipped then flipped in early trading after a sell ...